Publication | Open Access

Changes in subcellular doxorubicin distribution and cellular accumulation alone can largely account for doxorubicin resistance in SW-1573 lung cancer and MCF-7 breast cancer multidrug resistant tumour cells

Cellular AccumulationOncologyDoxorubicin ResistanceOncogenic AgentMedicinePathologyAnti-cancer AgentSubcellular Doxorubicin DistributionCancer BiologyCell BiologyLung CancerTumor BiologyCancer Growth